Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug - Global and China Top Players Market Share and Ranking 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030. The United States Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.
By segment, Hospital grew percent to account for percent of the total market sales, and Specialist Clinic grew percent.
Methicillin-resistant Staphylococcus aureus (MRSA) is a common bacterial infection pathogen that is more difficult to treat due to its resistance to conventional antibiotics such as methicillin. The most commonly used and most effective antibiotics are vancomycin, norvancomycin, and teicoplanin. Secondly, for patients with contraindications or intolerance of the above drugs, other antibacterial drugs, such as sodium fusidate, can also be used. In some countries and regions, ceftazidime, tigecycline, linezolid, daptomycin, etc. can also be used, all of which have good curative effects.
This report studies and analyses global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug status and future trends, helps the client to determine the Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug key producing regions, capacity, production, and year over year growth
(6) Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Basilea Pharmaceutica Ltd
The Medicines Company
Theravance Biopharma
Allergan
Merck & Co., Inc
Pfizer, Inc
Market segment by Type, covers
Lipopeptide
Oxazolidinone
Tetracycline
Cephalosporin
Lipoglycopeptide
Folate Antagonist
Other
Market segment by Application, can be divided into
Hospital
Specialist Clinic
Other
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, percent & CAGR, 2018-2029
Chapter 5: Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Definition
1.2 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast
1.2.1 By Consumption Value, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size，2019-2030
1.2.2 By Sales Quantity, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size，2019-2030
1.2.3 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP)，2019-2030
1.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size and Forecast
1.3.1 By Consumption Value, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size，2019-2030
1.3.2 By Sales Quantity, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size，2019-2030
1.3.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP)， 2019-2030
1.4 Share of China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market with Respect to the Global Market
1.4.1 By Consumption Value, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share in Global, 2019-2030
1.4.2 By Sales Quantity, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share in Global, 2019-2030
1.4.3 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size: China VS Global, 2019-2030
1.5 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Dynamics
1.5.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Drivers
1.5.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Restraints
1.5.3 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Trends
1.5.4 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, Global Market Share by Company, 2019-2024
2.2 By Sales Quantity of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, Global Market Share by Company, 2019-2024
2.3 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP) by Company, 2019-2024
2.4 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Concentration Ratio
2.6 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Mergers & Acquisitions, Expansion Plans
2.7 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers Product Type
2.8 Head Office and Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Site of Key Manufacturer
2.9 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, China Market Share by Company, 2019-2024
3.2 By Sales Quantity of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug, China Market Share by Company, 2019-2024
3.3 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity, Output and Capacity Utilization, 2019-2030
4.2 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity by Region
4.3 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production & Forecast by Region, 2019 VS 2024 VS 2030
4.4 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production by Region, 2019-2030
4.5 Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Market Share & Forecast by Region, 2019-2030
5 Industry Chain Analysis
5.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Chain
5.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Upstream Analysis
5.2.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Core Raw Materials
5.2.2 Main Manufacturers of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Mode
5.6 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Procurement Model
5.7 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Sales Model and Sales Channels
5.7.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Model
5.7.2 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Typical Distributors
6 Sights by Type
6.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Classification
6.1.1 Lipopeptide
6.1.2 Oxazolidinone
6.1.3 Tetracycline
6.1.4 Cephalosporin
6.1.5 Lipoglycopeptide
6.1.6 Folate Antagonist
6.1.7 Other
6.2 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030
6.3 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030
6.4 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030
6.5 By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP), 2019-2030
7 Sights by Application
7.1 Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Segment by Application
7.1.1 Hospital
7.1.2 Specialist Clinic
7.1.3 Other
7.2 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030
7.3 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030
7.4 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030
7.5 By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Price, 2019-2030
8 Sales Sights by Region
8.1 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019 VS 2024 VS 2030
8.2 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030
8.3 By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030
8.4 North America
8.4.1 North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug & Forecasts, 2019-2030
8.4.2 By Country, North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.5 Europe
8.5.1 Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.5.2 By Country, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.6.2 By Country/Region, Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.7 South America
8.7.1 South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & Forecasts, 2019-2030
8.7.2 By Country, South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size & CAGR, 2019 VS 2024 VS 2030
9.2 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030
9.3 By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030
9.4 U.S.
9.4.1 U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.4.2 By Type, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.5.2 By Type, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.6.2 By Type, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.7.2 By Type, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.8.2 By Type, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.9.2 By Type, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.10.2 By Type, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size, 2019-2030
9.11.2 By Type, Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Basilea Pharmaceutica Ltd
10.1.1 Basilea Pharmaceutica Ltd Company Information, Head Office, Market Area, and Industry Position
10.1.2 Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.1.3 Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.1.4 Basilea Pharmaceutica Ltd Company Profile and Main Business
10.1.5 Basilea Pharmaceutica Ltd Recent Developments
10.2 The Medicines Company
10.2.1 The Medicines Company Company Information, Head Office, Market Area, and Industry Position
10.2.2 The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.2.3 The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.2.4 The Medicines Company Company Profile and Main Business
10.2.5 The Medicines Company Recent Developments
10.3 Theravance Biopharma
10.3.1 Theravance Biopharma Company Information, Head Office, Market Area, and Industry Position
10.3.2 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.3.3 Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.3.4 Theravance Biopharma Company Profile and Main Business
10.3.5 Theravance Biopharma Recent Developments
10.4 Allergan
10.4.1 Allergan Company Information, Head Office, Market Area, and Industry Position
10.4.2 Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.4.3 Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.4.4 Allergan Company Profile and Main Business
10.4.5 Allergan Recent Developments
10.5 Merck & Co., Inc
10.5.1 Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
10.5.2 Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.5.3 Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.5.4 Merck & Co., Inc Company Profile and Main Business
10.5.5 Merck & Co., Inc Recent Developments
10.6 Pfizer, Inc
10.6.1 Pfizer, Inc Company Information, Head Office, Market Area, and Industry Position
10.6.2 Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
10.6.3 Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, Revenue, Price and Gross Margin, 2019-2024
10.6.4 Pfizer, Inc Company Profile and Main Business
10.6.5 Pfizer, Inc Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Tables & Figures:
Table 1. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million
Table 2. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Restraints
Table 3. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Trends
Table 4. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Policy
Table 5. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue Share by Company, 2019-2024, Ranked by Data of 2022
Table 7. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 9. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)
Table 10. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Mergers & Acquisitions, Expansion Plans
Table 12. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Manufacturers Product Type
Table 13. Head Office and Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Site of Key Manufacturer
Table 14. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity of Major Manufacturers and Future Plan
Table 15. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022
Table 16. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022
Table 17. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity by Company, 2019-2024, Ranked by Data of 2022
Table 18. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)
Table 19. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production by Region, 2019-2024, (K Units)
Table 20. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Upstream (Raw Materials)
Table 22. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Typical Customers
Table 23. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Typical Distributors
Table 24. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 25. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 26. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019 VS 2024 VS 2030, US$ Million
Table 27. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030, US$ Million
Table 28. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Table 29. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million
Table 30. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030, US$ Million
Table 31. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value Market Share, 2019-2030
Table 32. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Table 33. By Country, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2019-2030
Table 34. Basilea Pharmaceutica Ltd Company Information, Head Office, Market Area, and Industry Position
Table 35. Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
Table 36. Basilea Pharmaceutica Ltd Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 37. Basilea Pharmaceutica Ltd Company Profile and Main Business
Table 38. Basilea Pharmaceutica Ltd Recent Developments
Table 39. The Medicines Company Company Information, Head Office, Market Area, and Industry Position
Table 40. The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
Table 41. The Medicines Company Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 42. The Medicines Company Company Profile and Main Business
Table 43. The Medicines Company Recent Developments
Table 44. Theravance Biopharma Company Information, Head Office, Market Area, and Industry Position
Table 45. Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
Table 46. Theravance Biopharma Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 47. Theravance Biopharma Company Profile and Main Business
Table 48. Theravance Biopharma Recent Developments
Table 49. Allergan Company Information, Head Office, Market Area, and Industry Position
Table 50. Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
Table 51. Allergan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 52. Allergan Company Profile and Main Business
Table 53. Allergan Recent Developments
Table 54. Merck & Co., Inc Company Information, Head Office, Market Area, and Industry Position
Table 55. Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
Table 56. Merck & Co., Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 57. Merck & Co., Inc Company Profile and Main Business
Table 58. Merck & Co., Inc Recent Developments
Table 59. Pfizer, Inc Company Information, Head Office, Market Area, and Industry Position
Table 60. Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Models, Specifications, and Application
Table 61. Pfizer, Inc Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024
Table 62. Pfizer, Inc Company Profile and Main Business
Table 63. Pfizer, Inc Recent Developments
List of Figures
Figure 1. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Picture
Figure 2. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, (US$ million) & (2019-2030)
Figure 3. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, (K Units) & (2019-2030)
Figure 4. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP), (2019-2030) & (US$/Unit)
Figure 5. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, (US$ million) & (2019-2030)
Figure 6. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity (K Units) & (2019-2030)
Figure 7. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP), (US$/Unit) & (2019-2030)
Figure 8. By Consumption Value, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share of Global, 2019-2030
Figure 9. By Sales Quantity, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share of Global, 2019-2030
Figure 10. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Key Participants, Market Share, 2022
Figure 12. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity, Production and Capacity Utilization, 2019-2030
Figure 13. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Production Market Share & Forecast by Region, 2019-2030
Figure 15. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Industry Chain
Figure 16. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Procurement Model
Figure 17. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Model
Figure 18. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Channels, Direct Sales, and Distribution
Figure 19. Lipopeptide
Figure 20. Oxazolidinone
Figure 21. Tetracycline
Figure 22. Cephalosporin
Figure 23. Lipoglycopeptide
Figure 24. Folate Antagonist
Figure 25. Other
Figure 26. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030, US$ Million
Figure 27. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value Market Share, 2019-2030
Figure 28. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 29. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2019-2030
Figure 30. By Type, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 31. Hospital
Figure 32. Specialist Clinic
Figure 33. Other
Figure 34. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value, 2019-2030, US$ Million
Figure 35. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value Market Share, 2019-2030
Figure 36. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 37. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2019-2030
Figure 38. By Application, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Average Selling Price (ASP), 2019-2030, (US$/Unit)
Figure 39. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value Market Share, 2019-2030
Figure 40. By Region, Global Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2019-2030
Figure 41. North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 42. By Country, North America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value Market Share, 2022
Figure 43. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 44. By Country, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value Market Share, 2022
Figure 45. Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 46. By Country/Region, Asia Pacific Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value Market Share, 2022
Figure 47. South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 48. By Country, South America Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value Market Share, 2022
Figure 49. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Consumption Value & Forecasts, 2019-2030, US$ Million
Figure 50. U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 51. By Type, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, U.S. Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 53. Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 54. By Type, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Europe Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 56. China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 57. By Type, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, China Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 59. Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 60. By Type, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Japan Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 62. South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 63. By Type, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, South Korea Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 65. Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 66. By Type, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Southeast Asia Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 68. India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 69. By Type, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 70. By Application, India Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 71. Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity, 2019-2030, (K Units)
Figure 72. By Type, Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 73. By Application, Middle East & Africa Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Sales Quantity Market Share, 2022 VS 2029
Figure 74. Research Methodology
Figure 75. Breakdown of Primary Interviews
Figure 76. Bottom-up and Top-down Approaches
Figure 77. Top-down Approaches
Research Methodology:
Methicillin-Resistant Staphylococcus Aureus Infection Treatment Drug Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|